Model Medicines Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$8.38M
- Investors
-
9
Model Medicines General Information
Description
Developer of an artificial intelligence-driven drug discovery platform designed to accelerate the creation of life-changing drugs. The company offers a pipeline of patent-pending therapeutics for oncology, infectious diseases, gastric disorders, neurological disorders, and communicable diseases, enabling healthcare institutions to develop better medicines tailored to patients' needs.
Contact Information
Website
www.modelmedicines.comCorporate Office
- 5120 Shoreham Place
- Suite 285
- San Diego, CA 92122
- United States
Corporate Office
- 5120 Shoreham Place
- Suite 285
- San Diego, CA 92122
- United States
Model Medicines Timeline
Model Medicines Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Seed Round | 21-Oct-2026 | $8.38M | Completed | Generating Revenue | ||
| 4. Accelerator/Incubator | 10-Jun-2025 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue | |||
| 2. Seed Round | 11-Oct-2024 | $14.8M | $15.5M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 20-May-2021 | $750K | $750K | Completed | Generating Revenue |
Model Medicines Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-5 | ||||||||
| Seed-4 | ||||||||
| Seed-3 | ||||||||
| Seed-2 | 6,969,934 | $0.000100 | 6% | $0.56 | $0.56 | 1x | $0.56 | 12.46% |
| Seed-1 | 3,593,654 | $0.000100 | 6% | $1.14 | $1.14 | 1x | $1.14 | 6.43% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Model Medicines Comparisons
Industry
Financing
Details
Model Medicines Competitors (11)
One of Model Medicines’s 11 competitors is BigHat Biosciences, a Venture Capital-Backed company based in San Mateo, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BigHat Biosciences | Venture Capital-Backed | San Mateo, CA | ||||
| Relay Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Numerion Labs | Venture Capital-Backed | San Francisco, CA | ||||
| Genesis Molecular AI | Venture Capital-Backed | San Mateo, CA | ||||
| InSilico Medicine Cayman | Formerly VC-backed | Hong Kong, Hong Kong |
Model Medicines Patents
Model Medicines Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026198473-A1 | Computer-implemented systems and methods for compound mutagenicity assessment | Pending | 17-Mar-2025 | ||
| US-20260102384-A1 | Use of pipendoxifene for treating infections of dna viruses | Pending | 03-Jul-2024 | ||
| US-20260199314-A1 | Use of pipendoxifene for treating infections of dna viruses | Pending | 03-Jul-2024 | ||
| WO-2026011096-A1 | Use of pipendoxifene for treating infections of dna viruses | Pending | 03-Jul-2024 | ||
| WO-2026011096-A9 | Use of pipendoxifene for treating infections of dna viruses | Pending | 03-Jul-2024 | A61K31/454 |
Model Medicines Signals
Model Medicines Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BioTools Innovator | Accelerator/Incubator | |||
| MedTech Innovator | Accelerator/Incubator | |||
| 8VC | Venture Capital | Minority | ||
| Friedman BioVentures | Venture Capital | Minority | ||
| Irving Investors | Growth/Expansion | Minority |
Model Medicines FAQs
-
When was Model Medicines founded?
Model Medicines was founded in 2019.
-
Where is Model Medicines headquartered?
Model Medicines is headquartered in San Diego, CA.
-
What is the size of Model Medicines?
Model Medicines has 13 total employees.
-
What industry is Model Medicines in?
Model Medicines’s primary industry is Drug Discovery.
-
Is Model Medicines a private or public company?
Model Medicines is a Private company.
-
What is the current valuation of Model Medicines?
The current valuation of Model Medicines is .
-
What is Model Medicines’s current revenue?
The current revenue for Model Medicines is .
-
How much funding has Model Medicines raised over time?
Model Medicines has raised $23.9M.
-
Who are Model Medicines’s investors?
BioTools Innovator, MedTech Innovator, 8VC, Friedman BioVentures, and Irving Investors are 5 of 9 investors who have invested in Model Medicines.
-
Who are Model Medicines’s competitors?
BigHat Biosciences, Relay Therapeutics, Numerion Labs, Genesis Molecular AI, and InSilico Medicine Cayman are some of the 11 competitors of Model Medicines.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process